Covid-19: Longer interval between Pfizer doses results in higher antibody levels, research finds

An interval of at least six weeks between the two doses of the Pfizer-BioNTech covid-19 vaccine increased concentrations of neutralising antibodies, research funded by the Department of Health and…


Read Original Article: Covid-19: Longer interval between Pfizer doses results in higher antibody levels, research finds »